Where pharmaceutical strategy for Latin America gets decided.

Market intelligence, pricing and access for pharma and biotech companies with decisions pending in Argentina, Mexico, Paraguay, Uruguay and Chile. Each deliverable answers a defined question, with verified local evidence and a recommendation, at a timing and a price agreed in advance.

Map of Latin America showing the five Kovaris markets
12+
years of strategy and market access consulting for the pharmaceutical industry
50+
projects for pharma and biotech companies over the founder's career
5
markets: Argentina, Mexico, Paraguay, Uruguay and Chile

Packages

Four ways of working.

Argentina High-Cost Monitor

Quarterly report on reimbursement, centralized purchasing, prices and regulation for high-cost drugs in Argentina, with implications for the subscriber's portfolio.

From USD 1,500 per quarter

See the package →

Decision Sprint

One defined market, access or pricing question, answered in 10 business days with local evidence and a recommendation.

From USD 6,000

See the package →

KHIN Panel

The position and expected decisions of payers, physicians and regulators in one country regarding a product or a disease area, gathered through anonymous in-depth interviews, in about four weeks.

From USD 9,000

See the package →

Full Project

Opportunity assessment, business case, or access and pricing strategy, with a closed scope, in 6 to 8 weeks.

From USD 20,000

See the package →

Compare the four packages

For needs that do not fit these packages, Kovaris prepares custom proposals.

Why Kovaris

Local evidence, rebuilt.

Import records, public tenders, reimbursement data and list prices, consolidated and cross-checked, complemented by interviews with the people who decide coverage, prescribing and registration.

Short timelines with quality control.

Kovaris uses AI-assisted analysis tools to process sources, which makes delivery in days possible. Every data point is checked against its original source and every deliverable includes a methodology note.

Decision documents.

Each deliverable presents scenarios with explicit assumptions and closes with a recommendation the team can stand behind in front of regional management or the company it represents.

Recent experience

Three recent projects in the region

Paraguay · 2026

Market entry for a biotech company

A biotech company with a regional footprint needed to define its market entry routes and map the relevant stakeholders. Kovaris reviewed the coverage and purchasing routes for specialty products, the genetics, hemato-oncology and oncology centers, and the opinion leaders in each area. On that basis, the company set its entry plan and its first contacts.

Uruguay · 2025

Prioritizing therapeutic areas and products

A pharmaceutical company was assessing the entry of products from a manufacturing plant in India, across several therapeutic areas, and needed to set priorities. The areas were ranked by number of patients and feasibility of coverage by the Fondo Nacional de Recursos, the competition was analyzed and the registration requirements for each product were reviewed. The result was a prioritized list of molecules and a clear view of the requirements for entering the Uruguayan market.

Argentina · 2026 · Kovaris research

Pricing in hereditary angioedema

A reconstruction, from public sources, of how the price of icatibant moved when a second brand entered and then left the market, and of what the case shows about how a high-cost treatment is purchased and its price defended in Argentina. Published as a white paper in October 2026.

See all experience

First step: the decision your team needs to make.

An initial 30-minute call is used to set out the question and the scope; the proposal, with the price and the delivery date, follows in writing.